CAR Triggered Release of Type-1 Interferon Limits CAR T-Cell Activities by an Artificial Negative Autocrine Loop
The advent of chimeric antigen receptor (CAR) T cells expedited the field of cancer immunotherapy enabling durable remissions in patients with refractory hematological malignancies. T cells redirected for universal cytokine-mediated killing (TRUCKs), commonly referred to as “fourth generation” CAR T...
Main Authors: | Dennis Christoph Harrer, Charlotte Schenkel, Valerie Bezler, Marcell Kaljanac, Jordan Hartley, Markus Barden, Hong Pan, Astrid Holzinger, Wolfgang Herr, Hinrich Abken |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-11-01
|
Series: | Cells |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4409/11/23/3839 |
Similar Items
-
IRF4 downregulation improves sensitivity and endurance of CAR T cell functional capacities
by: Dennis Christoph Harrer, et al.
Published: (2023-05-01) -
Fine-tuning the antigen sensitivity of CAR T cells: emerging strategies and current challenges
by: Dennis Christoph Harrer, et al.
Published: (2023-11-01) -
Future of Electric and Hydrogen Cars and Trucks: An Overview
by: Aiman Albatayneh, et al.
Published: (2023-04-01) -
CAR T Cells: A Snapshot on the Growing Options to Design a CAR
by: Astrid Holzinger, et al.
Published: (2019-02-01) -
CAR T Cells Releasing IL-18 Convert to T-Bethigh FoxO1low Effectors that Exhibit Augmented Activity against Advanced Solid Tumors
by: Markus Chmielewski, et al.
Published: (2017-12-01)